Member Info for Aberdeenman

ODX can expand production by 180% with no capex costs.

They currently work 12/5, by extending to 24/7 they almost treble production.

When the very large orders are announced they will be able to scale quickly.

We know they are/have been recruiting.

Aberdeenman

"£5 SP, MCAP of £1.2Bn"

Some basic research may be advisable...

179,228,324 shares in issue, so a £5 SP makes £896,141,620 Market Cap

If you are unsure how to calculate a market cap, just ask.....

Aberdeenman

The interesting thing is it is for an initial 2 years, with a potential further 2 years....

There is likely to be need for ODX manufacturing for a long time!

Aberdeenman

The private Test & Trace set up by the Gov't at a near record low. 59.9% of close contacts traced, in a record week for infections diagnosed, 137,000.

As many advised them to do from the start, the local test and trace Systems, (Scotland is 100% local) cases managed by local health protection teams, 97.9% of contacts were reached.

Shocking example of ideology over health, this will have caused deaths and exacerbated the need for lockdowns.

Only way out of this is now mass testing, and LFT's are key to this.

https://www.theguardian.com/world/2020/nov/05/test-trace-reaches-six-10-covid-19-contacts-in-england-coronavirus

Aberdeenman

Thanks Vascular.

From the article:

"The government is relying on commercial companies to provide tests in kit form, rather than doing testing in government labs with existing equipment, and he thinks companies cannot provide enough of these tests for the whole country."

As I, and others, keep on saying, ODX will sell everything they can make.

at 2.5m tests a week this will be 300p+, if they can increase capacity, it just keeps on rising.

Aberdeenman

Thanks Vascular.

From the article:

"The government is relying on commercial companies to provide tests in kit form, rather than doing testing in government labs with existing equipment, and he thinks companies cannot provide enough of these tests for the whole country."

As I, and others, keep on saying, ODX will sell everything they can make.

at 2.5m tests a week this will be 300p+, if they can increase capacity, it just keeps on rising.

Aberdeenman

"There are millions of tests needed"

The Telegraph article, posted yesterday, mentioned 100m per month, that is a lot! If Bo Job is correct and they are indeed manufactured in the UK, then ODX will be manufacturing. 10m a month is a huge number.

Everything ODX make will be sold.

Aberdeenman

9 posts and an expert in company news.

How long ago was the last significant development??

Clue it concerned China.

Yet another ID for a deramper.

Aberdeenman

Whooo Hoo

Boom (big lol)

Aberdeenman

Agree, nothing doing that is a visible ramp, although it occurred to me that there may be a 'private group' pushing this.

That said, we are due some news, CB may well have earned his free shares.

Fingers crossed, a deal and this rerates.

Aberdeenman

"After watching Sir John Bell on CH4 News tonight i think someone has had a heads up..."

It is as I said earlier, they will need 10's of millions every week, ODX will sell evverything thy can manufacture.

Aberdeenman

looks like they have coordinated to try get the price down.

Usually a good sign, unfortunately, newbies do get worried, but anyone who has any sense and/or some experience can see what they are doing.

Aberdeenman

yawn

Aberdeenman

I agree Merchantbanker.

Everything they make will be sold.

I have tried to be very conservative and aim for a 500m market cap, based on some unknowns around proportions of tests in the capacity and smaller p/e multiple.

However, a 500m market cap seems certain, multiples of the current.

As I said there is no way Mologic will be able to cover the vast quantities of LFT tests required.

ODX are a mainstream manufacturer, hence part of the UKRTC, everything they make will be sold.

It is coming, and likely sooner than the derampers would wish.

Aberdeenman

for the usual reason.

Mologic capacity is 40m per annum for LFT, they do a lot of other stuff as well, but we are interested in LFT for Covid.

The UK will likely need 30-50m a WEEK next year, Mologic's 40m will all be used but are just a drop in the ocean.

ODX will be selling everything they make, and likely already know this. The pressure is on and I think the timescales will be accelerated.

Orders need to be made in advance as well as possible capacity payments, so likely this is all going to come together over the next couple/few weeks.

Investors are looking for the next big Covid riser, once the big orders start landing watch this move very fast.

Frustrating so far, but it is coming.

Aberdeenman

What interest do they have?

The usual.

Capacity of 2.5m tests coming, yes CAPACITY, what is needed is sales, I agree.

So you either think everything they make will be sold or not.

I also agree that PR has been a waste of time, they could get the receptionist to answer investor emails and save some money, for all the good they are doing.

But the end result is that they have to get orders. Bo Job has mentioned LFT's capable of being used at home, 'made in Britain' will be flooding the country, but we know that is not yet the case, so where are they going to come from?

Smart money say's Mologic will play a big part in that, which means orders, yes delivery may not be till Q1, but orders will come far sooner as it takes time to get the components, manufacture, package and distribute.

So there will come approvals (any time) then orders news will leak. Tech transfer can be accelerated based on orders.

Calm before the storm I would say.

ODX will become a spectacular riser based on ORDERS, we just do not know when.

Remember sentiment can turn very very fast.

Aberdeenman

"This one is just a basket case. £3 a share deary me................"

Have a look at GKP, went from 1.2p to 144.25 in two days, it was a basket case as well....until then.

Never say never.

That is the kind of return we are hoping for, you only need a few grand in (at least!) when news lands to give a massive return on the rerate, and well worth just switching off and waiting.

It is almost a binary, the deal gets done, this rockets, in the meantime why worry.

Fundamentally, the world, especially the Chinese, need the ore, big investment stimulus coming and geopolitics makes this attractive.

Aberdeenman

As frustrating as it is, and we are all feeling it, I doubt CB has been twiddling his thumbs.

Got to remember he has done it before, he knows the steps needed. He is not a green CEO, and although COVID has slowed things down, I sincerely think that there has been some substantive progress made, and that we will see evidence of it in the not too distant future.

Otherwise, what is the point? He won't need the money, nor the hassle.

Aberdeenman

It was a good idea to switch off for a few days during the small negative period just encountered.

And unsurprisingly, here we are again, all positive, and it looks like ODX will be in huge demand for their products, who would have guessed! Well, anyone with more than half a brain cell.

Nothing has changed in the fundamentals, maybe a few weeks longer than we hoped but everything still on track for a major rerate in the SP.

If anyone can tell me why the SP will not be multiples of the current SP in a matter of months then they must know something I do not.

We do not know all the timings, but it is certain that they are going to sell everything they make, and they are ramping up production as we speak.

MHRA approval and Mologic approvals and orders will see the SP rerate to new highs and levels, only question should be how much can you put into this.

Aberdeenman

One thing is for sure, if they get funding to move this forward, this will rocket.

No doubt that is what is keeping us here, either that or refusal to crystalise losses. ;-)

Aberdeenman